Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04255381 · ClinicalTrials.gov registry record · NA
Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04255381 is a NA study that has completed, run by Yale University. The registered enrollment target is 20 participants.
The verdict
NCT04255381, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The aim of this clinical study is to determine the feasibility, safety, and preliminary effectiveness of the Zone-Model Predictive Control Artificial Pancreas (ZMPC\_AP) system in pediatric subjects with type 1 diabetes in an ambulatory semi-supervised environment over a short duration of 3 days and 2 nights, or up to 60 hours.
Interventions
- DEVICE Zone-Model Predictive Control Artificial Pancreas (ZMPC_AP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04255381
The ClinicalTrials.gov registry entry for NCT04255381 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zone-Model Predictive Control Artificial Pancreas (ZMPC_AP) is the first listed.
NCT04255381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04255381 about?
NCT04255381 is a clinical study titled "Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID)". The aim of this clinical study is to determine the feasibility, safety, and preliminary effectiveness of the Zone-Model Predictive Control Artificial Pancreas (ZMPC\_AP) system in pediatric subjects with type 1 diabetes in an ambulatory semi-supervised environment over a short duration of 3 days and...
What is the current status of trial NCT04255381?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-10-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04255381?
The interventions under investigation include: Zone-Model Predictive Control Artificial Pancreas (ZMPC_AP) (DEVICE).
Who is sponsoring clinical trial NCT04255381?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.